ReviewFrontiers in cardiovascular medicine2026
Exploring nurse- and allied health professional-led opportunistic atrial fibrillation screening with artificial intelligence-enabled devices in community and primary care.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Undiagnosed atrial fibrillation (AF) is a leading cause of preventable ischemic stroke, particularly in the ageing populations. While traditional screening relies on physician-interpreted 12-lead electrocardiography (ECG), which is considered the gold standard, the increasing availiability of new artificial intelligence (AI)-enabled devices, such as single-lead ECG and photoplethysmography (PPG) tools, offer decentralised and scalable alternatives. This mini review argues that AI-enabled, nurse- and allied health professional (AHP)-led opportunistic screening represents a necessary paradigm shift in AF detection in the community and primary care setting. It is transitioning from a reactive, physician-dependent model to a proactive, community-based approach to provide early, timely and accessible interventions to reduce the risks of stroke. These devices have demonstrated good diagnostic accuracy when compared with ECG. Nurse-led opportunistic screening was found to be cost-effective and to reduce stroke risk by facilitating earlier anticoagulant initiation. Widespread adoption has been hindered by substantial barriers such as false positive results, a lack of standardised training, and liability concerns regarding AI interpretation. However, nurses and AHPs are uniquely positioned to lead opportunistic AF screening initiatives using AI technology. To maximise the clinical impact and solidify this new paradigm, future implementation strategies should prioritise workforce training, robust data governance, and the integration of AI findings into established clinical pathways to enable physician confirmation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.